News for Verve Therapeutics, Inc. (VERV)

Stocks Analysis by Investing.com (Thomas Monteiro) covering: Boeing Co, NVIDIA Corporation, Advanced Micro Devices Inc, Transocean Ltd. Read Investing.com (Thomas Monteiro)'s latest article on Investing.com

**media[531118]**

On December 31, 2024, Millennium Management LLC executed a significant transaction involving Verve Therapeutics Inc (NASDAQ: VERV). The firm reduced its holding

PR NewswireNEW YORK, Jan. 31, 2025 NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether cer

Verve Therapeutics (VERV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Initial data for the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in second quarter of 2025 Dosing in the Heart-2 trial has moved to

**media[509177]**

Soleno therapeutics' SVP Kristen Yen sells $222,483 in stock

**media[505213]**

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where Verve Therapeutics, Inc. (NASDAQ:VERV) stands against the other...

Vertex stock was floundering even before Thursday when the company's pain drug underperformed. Is Vertex Pharmaceuticals stock a sell?

Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my recommendation for VERV stock.

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of...

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

In this article, we will take a look at 14 best short-term stocks to invest in.

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Stocks that are trading heavily or have substantial price changes Monday: Verve Therapeutics, Immersion fall; Tower Semiconductor, Boeing rise

U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500, also rose, gaining, 1.31% to 4,429.89.